Obermeyer Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.68M Buy
3,992
+6
+0.2% +$2.39K 0.07% 89
2026
Q2
$1.44M Sell
3,986
-105
-3% -$35.9K 0.06% 101
2026
Q1
$1.44M Sell
4,091
-138
-3% -$49.2K 0.07% 95
2025
Q4
$1.38M Sell
4,229
-172
-4% -$54.6K 0.06% 92
2025
Q3
$1.24M Sell
4,401
-250
-5% -$72.5K 0.06% 95
2025
Q2
$1.3M Buy
4,651
+122
+3% +$34.6K 0.06% 90
2025
Q1
$1.41M Buy
4,529
+240
+6% +$70.9K 0.08% 83
2024
Q4
$1.12M Buy
4,289
+57
+1% +$16.9K 0.06% 94
2024
Q3
$1.36M Buy
4,232
+93
+2% +$30.4K 0.07% 91
2024
Q2
$1.29M Buy
4,139
+54
+1% +$15.9K 0.07% 89
2024
Q1
$1.16M Sell
4,085
-2
-0% -$585 0.07% 91
2023
Q4
$1.18M Buy
4,087
+169
+4% +$46K 0.08% 64
2023
Q3
$1.05M Buy
3,918
+1,105
+39% +$276K 0.08% 64
2023
Q2
$625K Sell
2,813
-110
-4% -$25.5K 0.04% 104
2023
Q1
$707K Sell
2,923
-36
-1% -$8.84K 0.05% 92
2022
Q4
$777K Hold
2,959
– – 0.06% 82
2022
Q3
$667K Buy
2,959
+38
+1% +$9.21K 0.05% 85
2022
Q2
$711K Buy
2,921
+110
+4% +$27K 0.05% 83
2022
Q1
$680K Sell
2,811
-519
-16% -$119K 0.04% 103
2021
Q4
$749K Hold
3,330
– – 0.04% 95
2021
Q3
$708K Hold
3,330
– – 0.04% 99
2021
Q2
$812K Hold
3,330
– – 0.05% 94
2021
Q1
$829K Buy
3,330
+2,094
+169% +$500K 0.05% 91
2020
Q4
$284K Sell
1,236
-152
-11% -$35K 0.02% 125
2020
Q3
$353K Sell
1,388
-300
-18% -$74.3K 0.03% 103
2020
Q2
$398K Sell
1,688
-58
-3% -$13.2K 0.03% 88
2020
Q1
$354K Sell
1,746
-278
-14% -$60.7K 0.04% 82
2019
Q4
$488K Buy
2,024
+15
+0.7% +$3.31K 0.04% 79
2019
Q3
$389K Sell
2,009
-291
-13% -$55.9K 0.04% 87
2019
Q2
$424K Sell
2,300
-200
-8% -$35.8K 0.04% 83
2019
Q1
$475K Hold
2,500
– – 0.04% 80
2018
Q4
$487K Hold
2,500
– – 0.05% 75
2018
Q3
$518K Buy
2,500
+200
+9% +$39.4K 0.04% 76
2018
Q2
$425K Sell
2,300
-1,725
-43% -$305K 0.04% 79
2018
Q1
$686K Sell
4,025
-436
-10% -$80K 0.06% 64
2017
Q4
$776K Buy
4,461
+72
+2% +$12.7K 0.07% 66
2017
Q3
$818K Sell
4,389
-147
-3% -$26K 0.07% 64
2017
Q2
$781K Buy
4,536
+750
+20% +$122K 0.07% 64
2017
Q1
$621K Hold
3,786
– – 0.06% 68
2016
Q4
$554K Sell
3,786
-150
-4% -$22.6K 0.05% 74
2016
Q3
$657K Buy
3,936
+1,872
+91% +$317K 0.06% 66
2016
Q2
$314K Hold
2,064
– – 0.03% 99
2016
Q1
$309K Sell
2,064
-3
-0.1% -$446 0.03% 98
2015
Q4
$336K Buy
2,067
+3
+0.1% +$472 0.03% 92
2015
Q3
$285K Hold
2,064
– – 0.03% 100
2015
Q2
$317K Hold
2,064
– – 0.03% 104
2015
Q1
$330K Sell
2,064
-300
-13% -$47.2K 0.03% 109
2014
Q4
$377K Buy
+2,364
New +$368K 0.03% 107

Other funds holding AMGN

Obermeyer Wealth Partners's AMGN Position: Q3 2026 in Review

Obermeyer Wealth Partners increased its Amgen (AMGN) stake by 0.15% in Q3 2026, buying an estimated $2.39K and bringing the position to 3,992 shares worth $1.68M. The position accounts for 0.07% of the portfolio, ranked #89.

Obermeyer Wealth Partners first reported a position in AMGN in Q4 2014 and has held it in 48 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Obermeyer Wealth Partners held 3,992 shares of Amgen worth $1.68M as of Q3 2026.
  • Obermeyer Wealth Partners bought 6 Amgen shares in Q3 2026, an estimated $2.39K.
  • Amgen made up 0.07% of Obermeyer Wealth Partners's portfolio in Q3 2026, its #89 holding.
  • Obermeyer Wealth Partners first reported a position in Amgen in Q4 2014 and has held it in 48 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Obermeyer Wealth Partners's 13F filing for Q3 2026, filed 21 Oct 2026.